Inactive Instrument

Press Releases Allena Pharmaceuticals, Inc.

Equities

ALNA

US0181191075

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

ALLENA PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-09-07	AQ
ALLENA PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	22-09-02	AQ
ALLENA PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-08-24	AQ
ALLENA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-15	AQ
ALLENA PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-08-11	AQ
ALLENA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-08-04	AQ
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease	22-07-19	GL
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease	22-07-19	AQ
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split	22-07-13	AQ
Allena Pharmaceuticals : Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split - Form 8-K	22-07-12	PU
ALLENA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split	22-07-12	GL
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split	22-07-12	AQ
ALLENA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
ALLENA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-08	AQ
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split	22-07-06	AQ
Allena Pharmaceuticals : Announces Rescheduling of Special Meeting to Approve Reverse Stock Split - Form 8-K	22-07-05	PU
ALLENA PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-07-05	AQ
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split	22-07-05	GL
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split	22-07-05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Allena Pharmaceuticals, Inc.

Equities

ALNA

US0181191075

Press Releases

Filters